home / endocrinology / 2018
Therapeutic Area
2018
Poster
Mifepristone therapy prior to pituitary surgery in Cushing disease prevented need for long-term glucocorticoid replacement
Annual Meeting of The Endocrine Society
2018
PosterA curious case of biochemical and clinical remission after treatment with mifepristone, a glucocorticoid receptor antagonist
Annual Meeting of The Endocrine Society
2018
PosterAdministration of localized progestin before mifepristone treatment may prevent endometrial thickening and breakthrough bleeding
Annual Meeting of The Endocrine Society
2018
PosterCombining amiloride and spironolactone to manage hypokalemia and edema in patients with Cushing syndrome being treated with mifepristone
Annual Meeting of The Endocrine Society
2018
PosterFKBP5 gene expression biomarker in ACTH-dependent Cushing syndrome patients pre- and postsurgery
Annual Meeting of The Endocrine Society
2018
PosterPhenotypic and metabolic improvements in a patient with equivocal findings of hypercortisolism treated with mifepristone: photographic and radiographic evidence
American Association of Clinical Endocrinology
2018
PosterMarked improvement in metabolic parameters in a patient with ACTH-independent hypercortisolism while on mifepristone
American Association of Clinical Endocrinology
2018
PosterMifepristone decreased the use of concentrated u500 insulin in patients with endogenous hypercortisolism who have type 2 diabetes mellitus
American Association of Clinical Endocrinology
2018
PosterOpen-label phase 2 study to assess safety and efficacy of relacorilant (cort125134), a selective cortisol modulator, in the treatment of endogenous hypercortisolism
American Association of Clinical Endocrinology
2018